Pharma channel feed

Marathon CEO tries to call a time out on con­tro­ver­sy as law­mak­ers rip in­to $89K de­flaza­cort price

9 years ago

Ac­tivists slam Im­munomedics’ $2B deal with Seat­tle Ge­net­ics in the mid­dle of a proxy war

9 years ago

The scoop: Marathon’s R&D pro­gram for Duchenne MD drug like­ly came in at a bar­gain base­ment price

9 years ago

Seat­tle Ge­net­ics grabs Im­munomedics’ tu­mor drug in $2B deal, shoot­ing for a quick OK

9 years ago
R&D

Neu­ro­crine adds a Parkin­son’s drug to its late-stage pipeline in $145M deal

9 years ago
R&D

Marathon's cheap, old steroid breezes through the FDA for Duchenne MD, and gets priced at $89K

9 years ago

Sanofi, Re­gen­eron win a cru­cial stay of ex­e­cu­tion on Pralu­ent

9 years ago

Af­ter clear­ing an FDA hur­dle, Am­gen wins an FDA OK on CKD drug Parsabiv

9 years ago

Two friends and biotech col­leagues with a pas­sion for in­sid­er in­fo - feds charge Mer­ri­mack staffer

9 years ago

As hep C rev­enue dis­in­te­grates, pres­sure keeps grow­ing on Gilead to do deals

9 years ago

White House: Trump re­mains com­mit­ted to Medicare drug price ne­go­ti­a­tions

9 years ago

A swarm of top biotech ex­ecs protest against Trump’s trav­el ban, say­ing it threat­ens the en­tire in­dus­try

9 years ago
People

With Trump’s new FDA com­mish nom­i­nee loom­ing, in­dus­try ex­ecs are keep­ing their fin­gers crossed for Scott Got­tlieb

9 years ago

Biotech deal­mak­er Ra­maswamy rais­es an­oth­er $55M for Ax­o­vant

9 years ago
Financing

Cy­to­ki­net­ics chief Blum grabs $100M roy­al­ty deal to fund an ex­pand­ed mar­ket­ing plan for PhI­II heart drug

9 years ago

Big Phar­ma promised Trump new Amer­i­can jobs for tax cuts and dereg­u­la­tion. But the vow comes af­ter a 5-year purge

9 years ago

An­a­lysts write off Di­men­sion’s lead pro­gram af­ter see­ing weak da­ta on he­mo­phil­ia B, shares plunge

9 years ago

Trump scolds phar­ma ex­ecs, de­mand­ing low­er prices, more US man­u­fac­tur­ing while promis­ing to slash FDA regs

9 years ago

On a deal spree, Take­da grabs Japan­ese cabo rights in $145M pact with Ex­elix­is

9 years ago

Fi­bro­Gen, As­traZeneca ready Chi­na ap­pli­ca­tion as ane­mia drug scores in two piv­otal stud­ies

9 years ago
R&D
China

In­cyte grabs con­trol of a can­cer drug from Calithera’s pipeline for $53M up front

9 years ago

Biotech ex­ecs slam Trump’s trav­el ban, count­ing the high cost to a glob­al in­dus­try

9 years ago

End­points Video spot­light: The de­bate over drug pric­ing takes cen­ter stage in 2017

9 years ago

Ex­perts fret over a new hir­ing freeze at the FDA. Will the fall­out be tox­ic to drug re­views?

9 years ago
First page Previous page 336337338339340341342 Next page Last page
A service from the Financial Times